Trial intelligence / Profile preview

Biafine vs Standard Care for Actinic Keratosis Wounds

NCT00695578Phase 4Completed

Sponsor
Wake Forest University
Start
Oct 2006
Primary completion
Jun 2007
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atopiclair in actinic keratosis (AK), sponsored by Wake Forest University. Started Oct 2006; status: completed.

02

Drugs

atopiclair
03

Conditions

actinic keratosis (AK)

Beyond the preview

Go deeper on NCT00695578.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00695578.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call